NEW YORK (GenomeWeb News) – Stem cell technologies company Cellular Dynamics International today announced it has filed with the US Securities and Exchange Commission to go public.

The Madison, Wis.-based firm filed its Form S-1 with SEC on Monday, saying it plans on an initial public offering to raise a maximum aggregate amount of $57.3 million. The price range for its shares and the number of shares to be offered have not been determined.

JP Morgan Securities is the sole book-running manager on the offering, while Cowen and Co. and Leerink Swann are co-managers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.